Cookies show us what works. Privacy
Cookies show us what works. Privacy
26 funds hold it · Insiders net selling
Net selling: insiders sold $810K and bought $10K on the open market in 90 days (SEC Form 4). Congress: net buying of $2K to $30K in 180 days.
Analyst target and ratings are on paid plans
Unlock the full resultsLast report
Aug 27, 2026
Period ending
Jul 31, 2026
Earnings per share
$1.19 expected
Revenue
Financial statements: Alpha Vantage
Estimates as of Nov 16, 2026
EPS expected
$1.13 to $1.19
Revenue expected
14 analysts
Last 30 days
Analysts raising estimates
| Quarter / reported | Earnings per share | Beat or miss | Revenue / income | Revenue vs last year |
|---|---|---|---|---|
| Jul 31, 2026Reported Aug 27, 2026 | $1.24est. $1.19 | +3.91%beat | $350.7MAlpha Vantage | +7.6%from $325.8M |
| Apr 30, 2026Reported May 28, 2026 | $1.24est. $1.12 | +11.18%beat | $354.6MAlpha Vantage | +7.2%from $330.8M |
| Jan 31, 2026Reported Mar 17, 2026 | $0.95est. $0.90 | +5.81%beat | $334.6MAlpha Vantage | +7.3%from $311.8M |
| Oct 31, 2025Reported Dec 3, 2025 | $1.01est. $0.91 | +10.71%beat | $322.2MAlpha Vantage | +7.2%from $300.4M |
| Jul 31, 2025Reported Sep 2, 2025 | $1.08est. $0.92 | +17.39%beat | $325.8MAlpha Vantage | +8.6%from $299.9M |
| Apr 30, 2025Reported Jun 3, 2025 | $0.97est. $0.81 | +19.75%beat | $330.8MAlpha Vantage | +15.0%from $287.6M |
| Jan 31, 2025Reported Mar 18, 2025 | $0.69est. $0.72 | -4.17%miss | $311.8MAlpha Vantage | +18.8%from $262.4M |
| Oct 31, 2024Reported Dec 9, 2024 | $0.78est. $0.72 | +8.33%beat | $300.4MAlpha Vantage | +20.5%from $249.2M |
Earnings per share comes from Yahoo Finance where available, then Alpha Vantage or the company release. Revenue comes from company releases, SEC filings, Alpha Vantage or Yahoo Finance. A beat or miss needs an analyst estimate on the same basis as the reported figure, so quarters without one show none. Non-USD amounts carry their currency code.
| USD | Oct 2025 | Jan 2026 | Apr 2026 | Jul 2026 |
|---|---|---|---|---|
| What came in | ||||
| Revenue | $322.2M | $334.6M | $354.6M | $350.7M |
| Cost of what it sold | $121.1M | $25.4M | $98.3M | $92.8M |
| Gross profit | $201.1M | $309.2M | $256.3M | $258.0M |
| What it spent | ||||
| Research and development | $65.9M | $70.4M | $67.8M | $73.9M |
| Sales and admin | $30.9M | $146.5M | $31.1M | $34.9M |
| Other operating costs | $24.4M | $24.9M | $54.5M | $50.5M |
| Total operating expenses | $121.2M | $241.8M | $153.4M | $159.3M |
| What was left | ||||
| Operating profit | $79.9M | $67.4M | $103.0M | $98.7M |
| Interest on debt | $14.0M | $13.3M | $12.6M | $12.6M |
| Profit before tax | $67.5M | $60.9M | $92.4M | $87.9M |
| Tax | $15.8M | $11.2M | $23.0M | $22.2M |
| Net profit | $51.7M | $49.7M | $69.4M | $65.6M |
| EBITDA | $120.4M | $100.7M | $131.5M | $142.4M |
This stock is in a strong uptrend.
Trend
Strong uptrend
100 / 100
RSI 14
20D volatility
52-week range
20D support
20D resistance
Returns
Price vs moving averages
Volume pace
Coverage leans bullish
HealthEquity Inc Lobbying Profile, 2020
NeutralNov 13Healthequity Inc stock hits 52-week high at 107.75 USD
BullishNov 4A Dec. 1 call will cover HealthEquity's third-quarter results.
NeutralNov 332 macro signals shaping HQY right now
Unlock sector rotation, regime shifts, and macro event windows tied to this stock.
Unlock the full results